Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at UC Davis
Dates
study started
estimated completion
Principal Investigator
by Guobao Wang, PhD (ucdavis)

Description

Summary

The primary objective is to measure the change between COVID-19 patients and normal subjects; the secondary objective is to measure the change in COVID-19 patients between baseline and 4-month follow up.

Keywords

Covid19 uEXPLORER/mCT

Eligibility

You can join if…

Open to people ages 18 years and up

  • COVID-19 positive patients will have a previous positive COVID-19 test and radiographic findings, and/or a positive SARS-CoV-2 antibody test and be in early recovery.
  • First PET/CT visit needs to be within 8 weeks of COVID-19 diagnosis.
  • Ability to understand and willingness to sign an informed consent form.
  • Ability to adhere to the study visit schedule and other protocol requirements.
  • All persons ≥18 years of age.

You CAN'T join if...

  • Pregnant or lactating women.
  • Any condition that would prohibit the understanding or rendering of informed consent.
  • Unable to lie supine for 1-hour imaging with PET.
  • Prisoners.
  • Any comorbidity that, in the opinion of the investigator, could compromise protocol objectives.

Location

  • University of California, Davis accepting new patients
    Sacramento California 95817 United States

Lead Scientist at UC Health

  • Guobao Wang, PhD (ucdavis)
    Associate Professor, Radiology. Authored (or co-authored) 49 research publications.

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, Davis
ID
NCT04841707
Study Type
Interventional
Last Updated